Anders Fink V.

Interim Chief Financial Officer, Consulting Role at Minervax

Anders Fink V. currently serves as the Interim Chief Financial Officer at Minervax ApS while also holding a Non-Executive Director position at Amplify Therapeutics ApS. Since 2015, Fink has been involved with Alpha Healthcare Investments ApS and Fink Consult ApS as a Financial Services Consultant. Previously, Fink was the Chief Executive Officer of Orphazyme A/S, overseeing a successful in-court restructuring and asset sale, and held several key positions, including Chief Financial Officer and CEO at Topotarget A/S, leading the company to a significant FDA approval and subsequent merger. Fink's earlier experience includes roles at BankInvest, 7TM Pharma, Copenhagen Capacity, and Carnegie Investment Bank, complemented by a strong educational background from prestigious institutions such as Harvard Business School and Copenhagen Business School.

Location

Copenhagen, Denmark

Links



Teams

This person is not in any teams


Offices

This person is not in any offices